Zobrazeno 1 - 10
of 112
pro vyhledávání: '"Andrzej S Januszewski"'
Autor:
Andrzej S Januszewski, Pawel Niedzwiecki, Nirupa Sachithanandan, Glenn M Ward, David N O’Neal, Dorota A Zozulinska‐Ziolkiewicz, Aleksandra A Uruska, Alicia J Jenkins
Publikováno v:
Journal of Diabetes Investigation, Vol 15, Iss 5, Pp 594-597 (2024)
ABSTRACT The gold standard for measuring insulin sensitivity (IS) is the hyperinsulinemic–euglycemic clamp, a time, costly, and labor‐intensive research tool. A low insulin sensitivity is associated with a complication‐risk in type 1 diabetes.
Externí odkaz:
https://doaj.org/article/94b1dbbb692c49ce985576f931b7a58b
Autor:
Emma S Scott, Rachel T McGrath, Andrzej S Januszewski, Daniel Calandro, Anandwardhan A Hardikar, David N O'Neal, Gregory Fulcher, Alicia J Jenkins
Publikováno v:
BMJ Open, Vol 9, Iss 12 (2019)
Objective To determine if continuous subcutaneous insulin infusion (CSII) therapy is associated with lower glycatedhaemoglobin (HbA1c) variability (long-term glycaemic variability; GV) relative to multiple daily injection (MDI) treatment in adults wi
Externí odkaz:
https://doaj.org/article/eedc699035514291bac3e348796fd150
Autor:
Prabin Gyawali, Sean A Martin, Leonie K Heilbronn, Andrew D Vincent, Alicia J Jenkins, Andrzej S Januszewski, Anne W Taylor, Robert J T Adams, Peter D O'Loughlin, Gary A Wittert
Publikováno v:
PLoS ONE, Vol 13, Iss 7, p e0200078 (2018)
Despite its widespread clinical use, there is little data available from population-based studies on the determinants of serum sex hormone binding globulin (SHBG). We aimed to examine multifactorial determinants of circulating SHBG levels in communit
Externí odkaz:
https://doaj.org/article/5afc4a2ba84f4e06bf3b9f42ef90fba5
Autor:
Andrzej S. Januszewski, David Chen, Russell S. Scott, Rachel L. O’Connell, Nanda R. Aryal, David R. Sullivan, Gerald F. Watts, Marja-Riitta Taskinen, Philip J. Barter, James D. Best, R. John Simes, Anthony C. Keech, Alicia J. Jenkins
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract People with diabetes are at risk of chronic complications and novel biomarkers, such as Advanced glycation end-products (AGEs) may help stratify this risk. We assessed whether plasma low-molecular weight AGEs, also known as LMW-fluorophores
Externí odkaz:
https://doaj.org/article/294b7a4d63544e699e028df0d5160f58
Autor:
Emma S. Scott, Andrzej S. Januszewski, Luke M. Carroll, Gregory R. Fulcher, Mugdha V. Joglekar, Anandwardhan A. Hardikar, Timothy W. Jones, Elizabeth A. Davis, Alicia J. Jenkins
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-4 (2021)
Abstract To determine whether continuous subcutaneous insulin infusion (CSII) vs. multiple daily injections (MDI) therapy from near-diagnosis of type 1 diabetes is associated with reduced glycaemic variability (GV) and altered microRNA (miRNAs) expre
Externí odkaz:
https://doaj.org/article/0adc48526a5746a2a86954d1d120e739
Autor:
Andrzej S. Januszewski, Yoon Hi Cho, Mugdha V. Joglekar, Ryan J. Farr, Emma S. Scott, Wilson K. M. Wong, Luke M. Carroll, Yik W. Loh, Paul Z. Benitez-Aguirre, Anthony C. Keech, David N. O’Neal, Maria E. Craig, Anandwardhan A. Hardikar, Kim C. Donaghue, Alicia J. Jenkins
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract The aim of this cross-sectional study was to compare plasma C-peptide presence and levels in people without diabetes (CON) and with Type 1 diabetes and relate C-peptide status to clinical factors. In a subset we evaluated 50 microRNAs (miRs)
Externí odkaz:
https://doaj.org/article/b1ec56fdb12a4c0cb5cb32be78d2f006
Autor:
Andrzej S. Januszewski, Chris J. Watson, Vikki O’Neill, Kenneth McDonald, Mark Ledwidge, Tracy Robson, Alicia J. Jenkins, Anthony C. Keech, Lana McClements
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-7 (2020)
Abstract Type 2 diabetes (T2D) is associated with increased risk of cardiovascular disease (CVD). As disturbed angiogenesis and endothelial dysfunction are strongly implicated in T2D and CVD, we aimed to investigate the association between a novel an
Externí odkaz:
https://doaj.org/article/ec07d944ce5f4cbf96962708943b5d15
Autor:
Wilson K.M. Wong, Mugdha V. Joglekar, Vijit Saini, Guozhi Jiang, Charlotte X. Dong, Alissa Chaitarvornkit, Grzegorz J. Maciag, Dario Gerace, Ryan J. Farr, Sarang N. Satoor, Subhshri Sahu, Tejaswini Sharangdhar, Asma S. Ahmed, Yi Vee Chew, David Liuwantara, Benjamin Heng, Chai K. Lim, Julie Hunter, Andrzej S. Januszewski, Anja E. Sørensen, Ammira S.A. Akil, Jennifer R. Gamble, Thomas Loudovaris, Thomas W. Kay, Helen E. Thomas, Philip J. O'Connell, Gilles J. Guillemin, David Martin, Ann M. Simpson, Wayne J. Hawthorne, Louise T. Dalgaard, Ronald C.W. Ma, Anandwardhan A. Hardikar
Publikováno v:
iScience, Vol 24, Iss 4, Pp 102379- (2021)
Summary: Dicer knockout mouse models demonstrated a key role for microRNAs in pancreatic β-cell function. Studies to identify specific microRNA(s) associated with human (pro-)endocrine gene expression are needed. We profiled microRNAs and key pancre
Externí odkaz:
https://doaj.org/article/016725883f2b42db88e23b368f58c758
Autor:
Andrzej S. Januszewski, Vallimayil Velayutham, Paul Z. Benitez-Aguirre, Maria E. Craig, Janine Cusumano, Alison Pryke, Stephen Hing, Gerald Liew, Yoon Hi Cho, Emily Y. Chew, Alicia J. Jenkins, Kim C. Donaghue
Publikováno v:
Diabetes Care. 45:2383-2390
OBJECTIVECurrent guidelines recommend biennial diabetic retinopathy (DR) screening commencing at the age of 11 years and after 2–5 years’ duration of type 1 diabetes. Growing evidence suggests less frequent screening may be feasible.RESEARCH DESI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7e3717647d44a100c86aa0b1cefcb1a
https://doi.org/10.2337/dc22-0071
https://doi.org/10.2337/dc22-0071
Autor:
Matthew B. O'Rourke, Andrzej S. Januszewski, David R. Sullivan, Imre Lengyel, Alan J. Stewart, Swati Arya, Ronald C. Ma, Sanjeev Galande, Anandwardhan A. Hardikar, Mugdha V. Joglekar, Anthony C. Keech, Alicia J. Jenkins, Mark P. Molloy
Funding: This work was performed by funding from The University of Sydney (CIA Jenkins) and funds provided by the National Health and Medical Research Council (Australia) APP1147897. Purpose: Robust, affordable plasma proteomic biomarker workflows ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02655d11181085ba624787daffb21aa1
https://hdl.handle.net/10023/27246
https://hdl.handle.net/10023/27246
